Voloridge Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,432
| Closed | -$393K | – | 1714 |
|
|
2020
Q4 | $393K | Buy |
8,432
+3,679
| +77% | +$171K | ﹤0.01% | 1175 |
|
|
2020
Q3 | $202K | Sell |
4,753
-14,043
| -75% | -$597K | ﹤0.01% | 1194 |
|
|
2020
Q2 | $902K | Sell |
18,796
-7,413
| -28% | -$356K | 0.01% | 886 |
|
|
2020
Q1 | $1.21M | Sell |
26,209
-4,602
| -15% | -$212K | 0.03% | 462 |
|
|
2019
Q4 | $1.85M | Buy |
+30,811
| New | +$1.85M | 0.04% | 508 |
|
|
2016
Q1 | – | Sell |
-42,136
| Closed | -$3.74M | – | 378 |
|
|
2015
Q4 | $3.74M | Buy |
+42,136
| New | +$3.74M | 0.27% | 94 |
|
|
2015
Q3 | – | Sell |
-8,674
| Closed | -$701K | – | 417 |
|
|
2015
Q2 | $701K | Buy |
+8,674
| New | +$701K | 0.04% | 242 |
|